Nf1 Loss and Ras Hyperactivation in Oligodendrocytes Induce NOS-Driven Defects in Myelin and Vasculature
View/ Open
Author
Mayes, Debra A.
Rizvi, Tilat A.
Titus-Mitchell, Haley
Oberst, Rachel
Ciraolo, Georgianne M.
Vorhees, Charles V.
Robinson, Andrew P.
Miller, Stephen D.
Cancelas, Jose A.
Ratner, Nancy
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1016/j.celrep.2013.08.011Metadata
Show full item recordCitation
Mayes, D. A., T. A. Rizvi, H. Titus-Mitchell, R. Oberst, G. M. Ciraolo, C. V. Vorhees, A. P. Robinson, et al. 2013. “Nf1 Loss and Ras Hyperactivation in Oligodendrocytes Induce NOS-Driven Defects in Myelin and Vasculature.” Cell reports 4 (6): 1197-1212. doi:10.1016/j.celrep.2013.08.011. http://dx.doi.org/10.1016/j.celrep.2013.08.011.Abstract
SUMMARY Patients with neurofibromatosis type 1 (NF1) and Costello syndrome Rasopathy have behavioral deficits. In NF1 patients, these may correlate with white matter enlargement and aberrant myelin. To model these features, we induced Nf1 loss or HRas hyperactivation in mouse oligodendrocytes. Enlarged brain white matter tracts correlated with myelin decompaction, downregulation of claudin-11, and mislocalization of connexin-32. Surprisingly, non-cell-autonomous defects in perivascular astrocytes and the blood-brain barrier (BBB) developed, implicating a soluble mediator. Nitric oxide (NO) can disrupt tight junctions and gap junctions, and NO and NO synthases (NOS1–NOS3) were upregulated in mutant white matter. Treating mice with the NOS inhibitor NG-nitro-L-arginine methyl ester or the antioxidant N-acetyl cysteine corrected cellular phenotypes. CNP-HRasG12V mice also displayed locomotor hyperactivity, which could be rescued by antioxidant treatment. We conclude that Nf1/Ras regulates oligodendrocyte NOS and that dysregulated NO signaling in oligodendrocytes can alter the surrounding vasculature. The data suggest that anti-oxidants may improve some behavioral deficits in Rasopathy patients.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982616/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:12152932
Collections
- HMS Scholarly Articles [17917]
Contact administrator regarding this item (to report mistakes or request changes)